fr
Article scientifique
Anglais

β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial

Publié dansJAMA internal medicine, vol. 174, no. 12, p. 1894-1901
Date de publication2014
Résumé

The clinical benefit of adding a macrolide to a β-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial.

Citation (format ISO)
GARIN, Nicolas et al. β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. In: JAMA internal medicine, 2014, vol. 174, n° 12, p. 1894–1901. doi: 10.1001/jamainternmed.2014.4887
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Identifiants
ISSN du journal2168-6106
654vues
0téléchargements

Informations techniques

Création15/11/2014 13:54:00
Première validation15/11/2014 13:54:00
Heure de mise à jour14/03/2023 22:29:22
Changement de statut14/03/2023 22:29:21
Dernière indexation16/01/2024 15:17:32
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack